Keywords: Sanofi, Selecta Biosciences, Immunotherapies, Allergies, Development

Sanofi inks up to $900 million allergy pact with Selecta Biosciences

Article | 28 November 2012

US clinical-stage biopharma company Selecta Biosciences revealed this morning that it has entered into a strategic global collaboration with French ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sanofi

Selecta Biosciences

Go to company listing